Opendata, web and dolomites

EUNCL SIGNED

European Nanomedicine Characterization Laboratory

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "EUNCL" data sheet

The following table provides information about the project.

Coordinator
COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES 

Organization address
address: RUE LEBLANC 25
city: PARIS 15
postcode: 75015
website: www.cea.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.eu-ncl.eu
 Total cost 5˙627˙303 €
 EC max contribution 4˙995˙181 € (89%)
 Programme 1. H2020-EU.1.4.1.2. (Integrating and opening existing national and regional  research infrastructures of European interest)
 Code Call H2020-INFRAIA-2014-2015
 Funding Scheme RIA
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2019-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES FR (PARIS 15) coordinator 944˙426.00
2    GESELLSCHAFT FUR BIOANALYTIK MUNSTER EV DE (MUNSTER) participant 866˙206.00
3    JRC -JOINT RESEARCH CENTRE- EUROPEAN COMMISSION BE (BRUSSELS) participant 827˙472.00
4    THE UNIVERSITY OF LIVERPOOL UK (LIVERPOOL) participant 650˙716.00
5    STIFTELSEN SINTEF NO (TRONDHEIM) participant 613˙910.00
6    THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN IE (DUBLIN) participant 442˙433.00
7    LEIDOS BIOMEDICAL RESEARCH INC US (FREDERICK MD) participant 273˙700.00
8    SINTEF AS NO (TRONDHEIM) participant 273˙436.00
9    EUROPEAN RESEARCH SERVICES GMBH DE (MUENSTER) participant 102˙880.00
10    EIDGENOSSISCHE MATERIALPRUFUNGS- UND FORSCHUNGSANSTALT CH (DUBENDORF) participant 0.00

Map

 Project objective

In order to accelerate the development of the nanomedicine business in Europe, EU-NCL interconnects 8 European and 1 American key reference facilities with a proven expertise in physical, chemical, in vitro and in vivo biological characterisation of nanoparticles for medical applications. The objective is to reach a level of international excellence in nanomedicine characterization for all medical indication, and make it accessible to all organisations developing candidate nanomedicines prior to their submission to the regulatory agencies in order to get the approval for clinical trials and later the marketing authorization. EU-NCL is partnered with the sole international reference facility namely the Nanotechnology Characterisation Lab of the USA to get a faster international harmonization of analytical protocols. EU-NCL is closely connected to national medicine agencies and to the European Medicine Agency in order to permanently adapt its analytical services to the need and requests of the regulators. EU-NCL is designed, organized and operated according to the highest EU regulatory and quality standards in order to provide a full analytical cascade of 42 assays. Within EU-NCL, 6 analytical facilities will offer a Trans National Access to their existing analytical services but they will also develop new or improved analytical assays under the Joint Research Activities in order to keep EU-NCL at the cutting edge of the nanomedicine characterisation. A complementary set of networking activities will make EU-NCL able to deliver to the European academic or industrial scientists the best analytical services they dramatically require for accelerating the industrial development of their candidate nanomedicines. An exploitation and business plan will be proposed at the end of the project in order to submit a sustainable development plan beyond the initial period of 4 years.

 Deliverables

List of deliverables.
1st report on modeling of analytical decision process Documents, reports 2019-05-28 15:42:58
Activities to promote innovation through partnership with industry – 2nd report Documents, reports 2019-05-28 15:42:47
Sample receiving laboratory installed Demonstrators, pilots, prototypes 2019-05-28 15:42:27
EU-NCL annual workshop –year 3 Websites, patent fillings, videos etc. 2019-05-28 15:42:56
1st Collection of approved measurement SOPs Demonstrators, pilots, prototypes 2019-05-28 15:42:31
2nd Completed survey with regulatory bodies Documents, reports 2019-05-28 15:42:59
1st report on reviews of QMS of EU-NCL Documents, reports 2019-05-28 15:42:29
1st List of candidate technologies Documents, reports 2019-05-28 15:42:51
2nd Data management plan Documents, reports 2019-05-28 15:42:35
Publication of 3rd TNA open call Websites, patent fillings, videos etc. 2019-05-28 15:42:42
1st Prioritized list of candidate technologies Documents, reports 2019-05-28 15:42:42
TNA “guide for applicant” & evaluation form Other 2019-05-28 15:42:30
CMS developed Other 2019-05-28 15:42:29
1st report on the testing and optimization of novel technologies Documents, reports 2019-05-28 15:42:57
Publication of 2nd TNA open call Websites, patent fillings, videos etc. 2019-05-28 15:42:48
CMS implemented Documents, reports 2019-05-28 15:42:35
Liaison activities with external stakeholders – 1st report Documents, reports 2019-05-28 15:42:33
Activities to promote innovation through partnership with industry– 1st report Documents, reports 2019-05-28 15:42:46
EU-NCL website Websites, patent fillings, videos etc. 2019-05-28 15:42:33
Publication of 1st TNA open call Websites, patent fillings, videos etc. 2019-05-28 15:42:33
EU-NCL annual workshop –year 2 Websites, patent fillings, videos etc. 2019-05-28 15:42:38
Appointment of the peer review evaluation board Other 2019-05-28 15:42:41
1st completed survey with regulatory bodies Documents, reports 2019-05-28 15:42:50
2nd Collection of approved measurement SOPs Demonstrators, pilots, prototypes 2019-05-28 15:42:24
2nd List of candidate technologies Documents, reports 2019-05-28 15:42:58
2nd Prioritized list of candidate technologies Documents, reports 2019-05-28 15:42:49
Publication of “State-of-the-art” manuscript – version 1 Websites, patent fillings, videos etc. 2019-05-28 15:43:00
3rd Collection of approved measurement SOPs Demonstrators, pilots, prototypes 2019-05-28 15:42:32
1st Data management plan Documents, reports 2019-05-28 15:42:31
2nd report on reviews of QMS of EU-NCL Documents, reports 2019-05-28 15:42:55

Take a look to the deliverables list in detail:  detailed list of EUNCL deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 F. Caputo, J. Clogston, L. Calzolai, M. Rösslein, A. Prina-Mello
Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity
published pages: 31-43, ISSN: 0168-3659, DOI: 10.1016/j.jconrel.2019.02.030
Journal of Controlled Release 299 2019-09-02
2017 Dora Mehn, Patrizia Iavicoli, Noelia Cabaleiro, Sven Even Borgos, Fanny Caputo, Otmar Geiss, Luigi Calzolai, François Rossi, Douglas Gilliland
Analytical ultracentrifugation for analysis of doxorubicin loaded liposomes
published pages: 320-326, ISSN: 0378-5173, DOI: 10.1016/j.ijpharm.2017.03.046
International Journal of Pharmaceutics 523/1 2019-06-12
2018 Fanny Caputo, Amandine Arnould, Maria Bacia, Wai Li Ling, Emilie Rustique, Isabelle Texier, Adriele Prina Mello, Anne-Claude Couffin
Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles
published pages: 756-767, ISSN: 1543-8384, DOI: 10.1021/acs.molpharmaceut.8b01033
Molecular Pharmaceutics 16/2 2019-04-19
2017 D. Mehn, F. Caputo, M. Rösslein, L. Calzolai, F. Saint-Antonin, T. Courant, P. Wick, D. Gilliland
Larger or more? Nanoparticle characterisation methods for recognition of dimers
published pages: 27747-27754, ISSN: 2046-2069, DOI: 10.1039/c7ra02432k
RSC Advances 7/44 2019-04-19
2018 Sabrina Gioria, Fanny Caputo, Patricia Urbán, Ciarán Manus Maguire, Susanne Bremer-Hoffmann, Adriele Prina-Mello, Luigi Calzolai, Dora Mehn
Are existing standard methods suitable for the evaluation of nanomedicines: some case studies
published pages: 539-554, ISSN: 1743-5889, DOI: 10.2217/nnm-2017-0338
Nanomedicine 13/5 2019-04-19

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EUNCL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EUNCL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.4.1.2.)

EMP (2019)

European Microkelvin Platform

Read More  

STRONG-2020 (2019)

The strong interaction at the frontier of knowledge: fundamental research and applications

Read More  

RISIS 2 (2019)

European Research Infrastructure for Science, technology and Innovation policy Studies 2

Read More